European patent attorney Philippa Griffin of Mathys & Squire appeared as a strawman in the appeal hearing. 10,480,025, titled "Labelled nucleotides"while . SAN DIEGO-- (BUSINESS WIRE)-- Illumina, Inc. (NASDAQ: ILMN) today announced that the High Court of Justice, Chancery Division, Patents Court, issued a judgment in its favor in the patent infringement suit filed against the BGI Companies, MGI Tech Co. Ltd; Latvia MGI SIA; MGI International Sales Co., Ltd; and BGI Complete Genomics Hong Kong Co., Tripadvisor picks two for top 10 in U.S. Endlessly curious La Jolla architect Eugene Ray still learning, imagining and creating at 90, Electric cars: More consumers now want to buy them, survey says, Boeing CEO loses $7M bonus, keeps $22.5 million compensation, Fashion Valley is getting a resort-style makeover, Ukraine ally Kallas fights for reelection in Estonia vote, Global race to boost electric vehicle range in cold weather, Paid express lanes grow more popular in once-reluctant South, Louisiana Gov. 0 Filed under Sequencing Business News Asia/Oceania lawsuit North America Hide Cookie Information. But in May, a Delaware jury decided that Illumina owes Complete Genomics more than $333 million for infringing on two patents, court documents state. Want more news? While Illumina claims that BGI and its subsidiaries willfully infringed five of its patents related to its DNA sequencing technology and is entitled to $25 million in damages, BGI says the. Host: https://www.illumina.com | In this case, the jury found Illumina willfully infringed on BGI/Complete Genomics patents related to two-channel techniques used in genomics sequencing. 19-cv-970, verdict issued 5/6/22. My name is Nava Whiteford. IP addresses), for example for personalized ads and content or ad and content measurement. 66 bus rattles just like a regular diesel bus on Chicagos west side, but no one seems to notice the high-pitched whine of the electric motor that makes it go, Privacy PolicyTerms of ServiceSign Up For Our NewslettersSite Map, Copyright 2023, The San Diego Union-Tribune |, Do Not Sell or Share My Personal Information, San Diegos Silvergate warns of more losses, viability of its business after crypto crisis, Carlsbads Viasat gets the green light for $7B Inmarsat deal as competition heats up in space, 6 Android smartphone makers eye Qualcomms Snapdragon Satellite to keep devices connected off the grid, San Diego online estate planning startup Trust & Will pulls in $15M in tough market for fundraising, Carlsbads Viasat inks deal with power utility in Mexico to bring Wi-Fi to hard-to-reach towns, Pfizer shedding more than 100 jobs at its San Diego research and development center, Biden expected to tighten rules on US investment in China, Scout Motors picks South Carolina for new $2B EV plant, Pot vote has Oklahoma hungry to rake in green from Texas, HOA Homefront HOAs have election questions, In Britain, warm hubs emerge to beat soaring energy costs, In Chicago, adapting electric buses to winters challenges. by Are there mutations in SARS-CoV-2 CDC qPCR Primer Sites? An Illumina spokesperson said the company plans to appeal and that the verdict should not affect its ability to supply its customers. If you disable this cookie, we will not be able to save your preferences. As a result, companies are now fighting hard for market share in this cutting-edge technology. The DNA sequencing patents are interesting for competitors such as MGI and the BGI Group, which are also in the . 6,730,777 and 6,984,487 licensed from The Regents of the University of Michigan and the HSC Research Development Limited Partnership. Many of the cases have settled, though some remain under appeal. CH Kilger (Berlin): Christian Kilger, Strawman So I expect Illumina to maintain a quality advantage. In particular its been disappointing to see the limited impact of sequencing on SARS-CoV2 diagnostics. In a later Delaware case, Complete Genomics accused Illumina of infringing on its own patents with two-channel sequencing systems, kits to prepare DNA fragments for sequencing and kits to immobilize, amplify and sequence fragments. Ive worked for a few sequencing companies. But in May, a Delaware jury decided that Illumina owes Complete Genomics more than $333 million for infringing on two patents, court documents state. These two patents appear to be the fundamental IP required to build an Illumina-style DNA sequencer. Justia Patents Patents Assigned to Illumina Patents Assigned to Illumina LAMINATE FLUIDIC CIRCUIT FOR A FLUID CARTRIDGE Publication number: 20230048094 Abstract: An apparatus includes a fluid reservoir and a laminate fluidic circuit positioned above the fluid reservoir. Hotjar is an user behavior analytic tool by Hotjar Ltd.. We use Hotjar to understand how users interact with our website. Illumina, or (ii) any expiration date or the end of the shelf-life pre-printed on the consumable, but in either event, no later than 12 months from the date of shipment. Invoking principles set out regarding sufficiency, the High Court contended that MGI infringed four of five of Illumina's valid patents. Show Cookie Information Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful. Analysts say the bad news is prompting investors to question the company's strategy of buying Grail, which Illumina forecasts will generate an operating loss of $670mn in 2023 on revenues of. According to an exhibitfiled with the complaint, Illumina said a BioRxivpreprintposted Feb. 20 proved CoolMPS technology infringed the '973 patent. Whats your favorite San Diego County beach? Illumina contends the verdict is not supported by the evidence presented at trial. You can find out more about which cookies we are using or switch them off in settings. Illumina Inc.owes BGI Group, the world's largest maker of commercial genetic sequencers, $333.8 million after a federal jury in Delaware found Friday that some of its DNA sequencing systems infringe two patents related to technology that deduces each nucleotide's identity from two signals. Each company sought a reasonable royalty for the alleged infringement of its patents by certain features of the accused products. IP addresses), for example for personalized ads and content or ad and content measurement. The patent covers a DNA sequencing method. You can find more information about the use of your data in our privacy policy. Harrods chief shrugs off recession fears because rich get richer, FCA regulator blamed for Arms decision to shun London listing, Argentina diary: Come armed with $100 bills, There are no domestic equity investors: why companies are fleeing Londons stock market, Clutching Warrens letter, Im still positive on stocks, The Murdaugh trial: a southern gothic tale that gripped the nation, Humanity is sleepwalking into a neurotech disaster, Who to fire? Tax Reg: 105-87-87282 | This is Not an Article on Data Protection and Competition Law. You may also opt to downgrade to Standard Digital, a robust journalistic offering that fulfils many users needs. Address of host server location: 5200 Illumina Way, San Diego, CA 92122 U.S.A. All trademarks are the property of Illumina, Inc. or their respective owners. %%EOF Well, I expect prices to do down, but I wouldnt expect Illumina to solely compete on price. Password (at least 8 characters required). df-mp Drries Frank-Molnia & Pohlman Patentanwlte Rechtsanwlte PartG mbB, filed apatent infringement counterclaim against Illumina, https://policies.google.com/privacy?hl=en, https://www.hotjar.com/legal/policies/privacy/, https://www.facebook.com/privacy/explanation, https://policies.google.com/privacy?hl=en&gl=en, https://wiki.osmfoundation.org/wiki/Privacy_Policy. The reversible terminator IP has not theyre currently using this IP to block the sale of some MGI instruments. or Patents. How much does it cost to ship 1cm^2 of silicon? This week, the EPO Boards of Appeal rejected Illuminas appeal concerningEP 2 325 304(T2248/14-3.3.08), resulting in the loss of the patent. You have to know whats happening with clients, competitors, practice areas, and industries. Can Shell close the valuation gap with US rivals? N choose K, with T targets. And I suspect is why theyre shopping around for acquisitions. Great! New configurations will bring longer read capabilities with more output for immune repertoire, shotgun metagenomics and more, Discover novel trait and disease associations with optimized tag SNPs and functional exonic content at an attractive price, DRAGEN v4.0 release enables machine learning by default, providing increased accuracy out of the box, Our instrument performance service helps reduce unplanned downtime and minimize instrument requalification, Robust methylation profiling microarray with extensive coverage of CpG islands, genes, and enhancers, Two DRAGENs help Cardio-CARE slay one petabyte of data to better understand heart disease in Hamburg, Together, were finding answers to lifes biggest questions and broadening the positive impact of genomics around the world, Get instructions for using Illumina DRAGEN Bio-IT Platform v4.0, Enable comprehensive genomic profiling with accurate and comprehensive homologous recombination deficiency assessment, Save on the Ribo-Zero Plus Microbiome rRNA Depletion Kit, restrictions apply, A multi-species, low-cost, genome-wide genotyping platform to support molecular breeding in small grains, A comprehensive, easy-to-implement, and versatile genomic analysis tool set for translational researchers, The NovaSeq 6000Dx is our first IVD-compliant high-throughput sequencing instrument for the clinical lab. In June 2019, Illumina filed the first lawsuit against BGI in the US, alleging that the Chinese company's sequencing technology infringed its own sequencing-by-synthesis chemistry, specifically US Patent Nos. Essential cookies enable basic functions and are necessary for the proper function of the website. The decision related to five of Illumina's patents for DNA sequencing technology: three of the patents (all divisionals) related to azidomethyl groups as reversible chain terminators ("RCTs") in sequencing by synthesis ("the modified nucleotide patents"); the fourth patent related to the use of ascorbic acid as a component in the . Compare Standard and Premium Digital here. So if youd be interest in investing in (or codeveloping) such a platform, get in touch. After spending the last 10-plus years in court, Illumina and BGI Group have reached a $325 million settlement to resolve a number of patent and antitrust claims across the US centered around the companies DNA sequencing technology. ), NPN Common Collector, Colpitts oscillator notes, NPN BJT Common emitter inverting amplifier, Simple example of SDL in Emscripten (generating graphics from C), Phase Shift Oscillator High Pass configuration, Astable multivibrator oscillator and a little oscillator history, Driving a tiny stepper on an Arduino (without a driver! The Illumina In-Licensed Patents as of the Effective Date are set forth on Annex II, provided that on and after the Effective Date, the Patents set forth on Annex IV (in-licensed by Sequenom from CUHK) shall be deemed added to Annex II, and Annex IV shall be deemed to no longer include any Patents. Further strawmen were patent attorney Leo Polz and Christian Kilger. The evidence also showed that BGI had copied numerous components of Illuminas technology, including its imaging buffer used in Illuminas sequencing-by-synthesis technology and infringed Illuminas patents related to that technology.. Law360 provides the intelligence you need to remain an expert and beat the competition. Illumina MiSeq Dx Cystic Fibrosis Assays, TruSeq Stranded total RNA Sample Prep Kits, BaseSpace Cohort Analyzer Related Products, BaseSpace Variant Interpreter Related Products, BaseSpace Correlation Engine Related Products. The Court found that four of the five asserted patents were valid and . We use cookies on our website. Click here to login, 2023, Portfolio Media, Inc. | About | Contact Us | Legal Jobs | Advertise with Law360 | Careers at Law360 | Terms | Privacy Policy | Cookie Settings | Help | Site Map, Enter your details below and select your area(s) of interest to stay ahead of the curve and receive Law360's daily newsletters, Email (NOTE: Free email domains not supported). The purchase of this product from Illumina, Inc., its affiliates, or its authorized resellers and distributors conveys to the buyer the non-transferable right to use the purchased amount of the product and components of the product by the buyer (whether the buyer is an academic or for-profit entity). The European Patent Office has destroyed several patents belonging to Illumina, a US manufacturer of genetic engineering equipment. Reach him at blake.brittain@thomsonreuters.com. [1/2]A new office building housing genetic research company Illumina is shown in San Diego, California, U.S., May 30, 2018. IP addresses), for example for personalized ads and content or ad and content measurement. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics. Competitors in this market include the German company Qiagen and the Chinese manufacturer of genetic sequencers BGI Group, as well as MGI. How the biggest companies plan mass lay-offs, The benefits of revealing neurodiversity in the workplace, Tim Peake: I do not see us having a problem getting to Mars, Our ski trip made me question my life choices, Michelle Yeoh: Finally we are being seen, Apocalypse then: lessons from history in tackling climate shocks, How Glasgows tiny, muckraking crime mag stays afloat, Smart data to help spot risk and opportunity, Lex, our agenda-setting business commentary (Premium only), Due Diligence, an exclusive M&A newsletter (Premium only). The license is limited to Illumina's current technology used for massively parallel sequencing in . cookies The case centers on 2019 lawsuit filed by Complete Genomics a U.S. subsidiary of Chinese genomics company BGI Group. offers FT membership to read for free. Theyre iterated over the original IP pretty well and have a number of other advantages over new players specifically: This is all technology was developed for Hiseqs and later instruments. Illumina has. Scripts to download SARS-CoV-2 replacements, Sony CCD-V8AF Video Camera Recorder Viewfinder CRT Notes, Playing with a Handycam CCD-F340 Viewfinder CRT Notes, Thoughts on a new approach to viral testing, Quick script to download Uniprot info for proteins from Pfam trees (Newick tree format), Notes on fixing a broken Gentoo grub install, Notes on using a ILX511 Linear CCD, AD9225 ADC, ICE40HX8K and Nmigen, Thoughts on interviewing with YC as a science based startup, 2018 DNA Sequencing Raises and Acquisitions. Some of them are essential, while others help us to improve this website and your experience. The listed products and their use are the subject of US Patent Nos. Essentially for everything else available or on the horizon the data quality is not as good and COGS is higher than the Illumina approach. It has the same estimated expiration as the first patent. Of course there are other approaches on the market or in development. Cookie by Google used to control advanced script and event handling. Not for import or sale to the Australian general public. 9,085,798; 9,783,847; 10,000,800 and related patents and patent applications. A spokesperson for MGI Tech Co., which owns Complete Genomics, said MGI is pleased with verdict. The stock closed Friday up 7.4. The jury's verdict follows the decision of Judge William Orrick, in the same case, to award Illumina summary judgment on claims of infringement by BGI's StandardMPS and CoolMPS products. Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile. PLEASE NOTE: A verification email will be sent to your address before you can access your trial. BGI Group, a genome sequencing company based in China, on Monday escalated its global intellectual property fight with rival Illumina Inc by filing a U.S. patent case against the California-based . The DNA sequencing patents are interesting for competitors such as MGI and the BGI Group, which are also in the midst of patent infringement claims. An Encoding And Correction Approach for DNA Data Storage, Using an SBS-like approach to selectively amplify, Reprogramming a ATTINY85 to use an external oscillator using the Arduino IDE, Nanopore DNA Sequencing Research Groups (August 2018), DNA Sequencing Companies (Updated May 2020), Inheco Control 96 + CPAC Ultraflat Notes (TEC/Peltier), Veeco/Bruker AFM (nanosope) head teardown pics, uMD1 ChipKIT 32 HP Interferometer Interface, Penrose Puzzle Lessons Learned from Rev 0, Embedding Electronics in Transparent Resin, Another iPhone MEMS Mic (different configuration+layers), Throwing the BME280 Combined Pressure/Humidity Sensor in a SEM, MXq Quad Core Android Thoughts (and console kernel messages), 11inch Celestron CPC Series Telescope Repair Initial Photos, A Brief Computational Analysis of Pen-Pineapple Apple-pen, esp32 USB Stick (esp32 + ch340g + buck conv + sd card), FG-100 Soldering Iron Tip Temperature Sensor, Fiddling with a cheap 5 port dumb switch to add VLANs/port mirroring, Marking intervals in gnuplot graph (with shading), awk print text between 2 identical markers in a file, A git pre-commit hook to do SVN style $Date$ substitution, Sony WPSD5 Surround Sound System repair Notes, Interfacing Hitachi HD44780 LCDs using I2C on an Arduino, Notes on Genias new paper nanopore SBS, Are you sure this isnt horse? 7,566,537 and 9,410,200. The case is Complete Genomics Inc. v. Illumina Inc., D. In the Delaware case, San Jose, California-based Complete Genomics Inc, a BGI subsidiary, had challenged Illumina's "two-channel" sequencing systems and kits to prepare DNA fragments for sequencing of violating its patent rights. So the cluster and nucleotide IP are really the key to producing an Illumina-style DNA sequencer. He said the company is also pleased that the jury invalidated the cases three Illumina patents. Interpretation, Certificates (CofC, CofA) and Master Lot Sheets, AmpliSeq for Illumina Cancer Hotspot Panel v2, AmpliSeq for Illumina Comprehensive Cancer Panel, Breast Cancer Target Identification with High-Throughput NGS, The Complex World of Pan-Cancer Biomarkers, Microbiome Studies Help Refine Drug Discovery, Identifying Multidrug-Resistant Tuberculosis Strains, Investigating the Mysterious World of Microbes, IDbyDNA Partnership on NGS Infectious Disease Solutions, Infinium iSelect Custom Genotyping BeadChips, 2020 Agricultural Greater Good Grant Winner, 2019 Agricultural Greater Good Grant Winner, Gene Target Identification & Pathway Analysis, TruSeq Methyl Capture EPIC Library Prep Kit, Genetic Contributions of Cognitive Control, Challenges and Potential of NGS in Oncology Testing, Partnerships Catalyze Patient Access to Genomic Testing, Patients with Challenging Cancers to Benefit from Sequencing, NIPT vs Traditional Aneuploidy Screening Methods, SNP Array Identifies Inherited Genetic Disorder Contributing to IVF Failures, NIPT Delivers Sigh of Relief to Expectant Mother, Education is Key to Noninvasive Prenatal Testing, Study Takes a Look at Fetal Chromosomal Abnormalities, Rare Disease Variants in Infants with Undiagnosed Disease, A Genetic Data Matchmaking Service for Researchers, Using NGS to Study Rare Undiagnosed Genetic Disease, Progress for Patients with Rare and Undiagnosed Genetic Diseases. Additional patent lawsuits have been filed in Denmark, Finland, Germany, Sweden, Switzerland, Turkey and the United Kingdom. If External Media cookies are accepted, access to those contents no longer requires manual consent. Imprint. No one on our HOA board has been elected and they all remain on by default year after year. university Illumina invented its 2-channel technology before the BGI patents, and BGI was unable to make 2-channel chemistry work until it copied Illuminas technology, said the company is a statement. The European patent attorney also regularly files patents for the US company at theEPO. Complete Genomics is represented by Young Conaway Stargatt & Taylor LLP and Quinn Emanuel. On November 30, 2021, a jury in the patent infringement suits between Illumina, Inc. and BGI Genomics Co. in the U.S. District Court for the Northern District of California returned a verdict invalidating certain patent claims of Illumina's U.S. Patent No. You can revoke or adjust your selection at any time under Settings. We use cookies and other technologies on our website. Statistics cookies collect information anonymously. The company also filed an anticompetitive suit against Illumina in Delaware last year. Illumina's '973 patent is expected to expire in 2023 and the '444 patent in 2024. The listed products and their use are the subject of the following US Patent Nos. So I imagine what theyll do is reduce pricing so that theyre competitive but not the cheapest option. Griffins clients include New England Biolabs and the Ecole Polytechnique Fdrale De Lausanne (EPFL). 249 0 obj <>/Filter/FlateDecode/ID[<6552C99E7534134FBECC31BE4AF41116>]/Index[229 30]/Info 228 0 R/Length 101/Prev 92673/Root 230 0 R/Size 259/Type/XRef/W[1 3 1]>>stream The patents in that case expire in August 2022 and January 2023. You may occasionally receive promotional content from the San Diego Union-Tribune. hbbd```b`` Personal data may be processed (e.g. You can find more information about the use of your data in our privacy policy. travels to Asia to strengthen business ties, How major US stock indexes fared Friday 3/3/2023, VMware, Broadcom rise; Marvell, Bumble fall. The listed products and their use are the subject of the following US Patent Nos. BGIs suit targeted Illumina systems including the NovaSeq 6000, the NextSeq 500/550/550x and 1000/2000 Series, and the MiniSeq. For a full comparison of Standard and Premium Digital, click here. %PDF-1.5 % We are using cookies to give you the best experience on our website. You can give your consent to whole categories or display further information and select certain cookies. Illumina's shares dropped sharply following the verdict but have rebounded somewhat since. Any changes made can be done at any time and will become effective at the end of the trial period, allowing you to retain full access for 4 weeks, even if you downgrade or cancel. Analysts say the bad news is prompting investors to question the company's strategy of buying Grail, which Illumina forecasts will generate an operating loss of $670mn in 2023 on revenues of. 10,480,025 (the '025 Patent) asserted against BGI in the suit, which are directed to blocked We do not anticipate that this decision will affect our ability to supply and service our customers.. Already a subscriber? Personal data may be processed (e.g. All quotes delayed a minimum of 15 minutes. In July 2019, Illumina filed counterclaims alleging certain models of the BGISEQ and MGISEQ genetic sequencing instruments infringe three Illumina patents. Privacy Policy But they probably wont be the only player to take this approach. BGI countersuedmonths later. As of right now, it seems that Illuminas original cluster generation IP has expired (from Manteia) has expired. The industry leader for online information for tax, accounting and finance professionals. Blake Brittain reports on intellectual property law, including patents, trademarks, copyrights and trade secrets. Complete Genomics filed the suit in May 2019, claiming San Diego-based Illuminas two-channel DNA sequencing systems infringe a patent for the technology, which deduces the identity of each nucleotide from two signals. It is Illumina's policy to seek patent protection in the United States and abroad for such technology and products. The above analysis relies on the fact that the COGS of competitors is probably going to be similar to Illumina. This latest settlement should put an end to the storm of lawsuits at least for a while. The European Patent Office has destroyed several patents belonging to Illumina, a US manufacturer of genetic engineering equipment. The reversible terminator IP has not they're currently using this IP to block the sale of some MGI instruments. Try full digital access and see why over 1 million readers subscribe to the FT, Purchase a Trial subscription for $1 for 4 weeks, You will be billed $69 per month after the trial ends, Russian far-right fighter claims border stunt exposes Putins weakness, Something is boiling: Turkish football fans tackle Erdoan, Three-day weekends and more time for love: Chinas elite dream up policies for Xi, Germany and Italy stall EU ban on combustion engines, Feds Daly says US rates likely to be higher for longer, Saudi owner of Londons most expensive house sued over alleged unpaid private jet bills, Why the Jeffrey Epstein scandal continues to haunt JPMorgan and Barclays, US electric vehicle batteries poised for new lithium iron age. By Hannah Albarazi (November 19, 2021, 10:09 PM EST) -- A California federal jury heard testimony Friday from gene sequencing company Illumina's expert witness that 10 judges who previously upheld Illumina's patents behind its next-generation technology "got it right," one day after Chinese-owned DNA sequencing company Complete Genomics offered expert testimony that Illumina's patents are invalid as obvious. U.S. District Court for the Northern District of California, Access to case data within articles (numbers, filings, courts, nature of suit, and more. Judge William H. Orricks March 27 order in the U.S. District Court for the Northern District of California resolved a spate of issues in two suits between the rivals, including by its denial of BGIs bid for a new trial. This is the first time the UK patent courts have truly grappled with sufficiency at a lower instance. Additionally, Natera has granted Illumina a non-exclusive license to Natera's '592 Patent family. Illumina's patent portfolio reflects the incredible innovation of Illumina's employees and the investment of hundreds of millions of dollars that Illumina spends annually on research and . Illumina has sought to stay ahead by expanding its portfolio of sequencers. 258 0 obj <>stream Limited Use Label License: This product and its use are the subject of one or more issued and/or pending US and foreign patent applications owned by Max Planck Gesellschaft, exclusively licensed to New England Biolabs, Inc. and sublicensed to Illumina, Inc. Illumina and BGI/Complete Genomics have been fighting over patents since 2010, with about a dozen legal actions in various U.S. federal courts. At the moment there doesnt seem to be any effective competition to Illumina. Probability of choosing at least one target, Ubuntu 20.04 Fujitsu FAREHT1 Mouse/Touch Screen Fixes, Beckman DU530 Spectrophotometer CFL Spectra, Beckman DU530 Photospectrometer (Hach DR4000?) Accept all It uses mutant DNA polymerase enzymes in nucleic acid sequencing reactions, which is particularly important for sequencing-by-synthesis. 6 February 2023 & Pipeline Setup, Sequencing Data "," m.t`2L*] Xl2$cb8PQF = Opponents included strawmen as well as Qiagen, a Germany-based provider of DNA sequencing technology. Simply log into Settings & Account and select "Cancel" on the right-hand side. Q. The listed products and their use are the subject of US Patent Nos. The costs of this technology have fallen sharply in recent years. Illumina, Inc. (NASDAQ: ILMN) today announced that the High Court of Justice, Chancery Division, Patents Court, issued a judgment in its favor in the patent infringement suit filed against the BGI Companies, MGI Tech Co. Ltd; Latvia MGI SIA; MGI International Sales Co., Ltd; and BGI Complete Genomics Hong Kong Co., Ltd. In addition, although Complete Genomics may seek an injunction, we do not believe there is a reasonable basis for the court to grant one, said Illumina in the filing. BGI and Illumina are both major providers of genome-analysis technology used to detect genetic diseases. One is estimated to expire in December 2025, another in January 2026the jury found BGIs products infringe those twoand a third in February 2026. Law360 may contact you in your professional capacity with information about our other products, services and events that we believe may be of interest.Youll be able to update your communication preferences via the unsubscribe link provided within our communications.We take your privacy seriously. other approaches on the market or in development.
Shannon Mayfield Principal,
Fatal Wreck Yesterday,
Convert Array To Integer Python,
Articles I